Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by porksnifferon Feb 14, 2020 2:56pm
123 Views
Post# 30693143

RE:From GUD to GREAT

RE:From GUD to GREAT
GoldenInvestor wrote:
what a year this is set to be, what a Company KNIGHT is set to become!
 
Of GUD products:
 
Only marketed 3 of 17 products based on 2018 annual report!
 
All others are in development of procedures, regulations , clinical , etc...
 
BIOTOSCANA:
 
10 LATAM countries with discovery, development and possible cross-marketing potential
 
- population size how much greater than Canada?
- 600+ people to work in labs and discovery ++ in GBT
- HOW MANY PRODUCTS AND EXTRA PENETRATION
 
-seems like investors in KNIGHT are currently filling up and trying to get as many shares as possible before high pressure growth with all development!
 
PLEASE COMMENT AND CRITIQUE!
 
VAMANOS!!  
 



I can't tell if this is sarcasm or serious considering the stock is a few dimes away from a new 4 year low. Out of 4000 companies in Canada there are about 15-20 hitting new lows and most of those are weed stocks. We will soon be joing that list in a raging bull market, an incredible accomplishment to be honest. The market is a voting machine and the price reflects what the market thinks about this company and it's terrible management.
Bullboard Posts